# Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders

> **NCT04725383** · PHASE3 · TERMINATED · sponsor: **University of Missouri, Kansas City** · enrollment: 1 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Repetitive Compulsive Behavior

## Interventions

- **DRUG:** amitriptyline

## Key facts

- **NCT ID:** NCT04725383
- **Lead sponsor:** University of Missouri, Kansas City
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-11-01
- **Primary completion:** 2025-05-23
- **Final completion:** 2025-05-23
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** The PI is retiring.
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04725383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04725383, "Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04725383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*